Modus Operandi
Climate Change Research Gets Closer to Nature
Climate Change Research Gets Closer to Nature
Ruth Williams | Jul 1, 2018
Researchers devise more-realistic means of forecasting the effects of climate change on complex marine ecosystems.
Gene Expression Analysis Gets Gassy
Gene Expression Analysis Gets Gassy
Ruth Williams | Jun 1, 2018
Soil scientists use a gas-producing reporter system to assess gene activity in bacteria.
Mitochondrial Isolation System
Mitochondrial Isolation System
Ruth Williams | May 1, 2018
A transgenic approach allows researchers to collect the organelles from specific cells in nematodes with unprecedented efficiency.
Infographic: Isolating mitochondria from specific cell types
Infographic: Isolating mitochondria from specific cell types
Ruth Williams | May 1, 2018
Adding a fusion gene to certain mitochondria in C. elegans enables researchers to collect and analyze them.
Synthetic Stem Cells Regenerate Heart Tissue in Mice
Synthetic Stem Cells Regenerate Heart Tissue in Mice
Diana Kwon | Jun 1, 2017
These engineered “cells” were made from the secretions and membranes of human mesenchymal stem cells.
Contributors
Contributors
Diana Kwon | Jun 1, 2017
Meet some of the people featured in the June 2017 issue of The Scientist.
Infographic: How to Make an Artificial Stem Cell
Infographic: How to Make an Artificial Stem Cell
Diana Kwon | May 31, 2017
See researchers' recipe for synthetic mesenchymal stem cells, which showed cardiac regenerative potential in mice.
Phosphorylation at the Flick of a Switch
Phosphorylation at the Flick of a Switch
Ruth Williams | May 1, 2017
Incorporating light-controlled dimerization domains into kinases provides tight regulation of these enzymes.
Infographic: Enzymes Controlled by Light
Infographic: Enzymes Controlled by Light
Ruth Williams | Apr 30, 2017
Custom-designed kinases have built-in switches that act as gatekeepers for the enzymes' active sites.
Targeting Tregs Halts Cancer’s Immune Helpers
Targeting Tregs Halts Cancer’s Immune Helpers
Ruth Williams | Apr 1, 2017
New monoclonal antibodies kill both cancer-promoting immunosuppressive cells and tumor cells in culture.